Diseases, Conditions, Syndromes

A novel tuberculosis regimen shortens treatment course for patients

Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete ...

Diseases, Conditions, Syndromes

The tuberculosis health crisis in Latin American jails

High rates of tuberculosis (TB) in Latin American prisons are subverting efforts to control the disease in the wider population, and constitute a "health and human rights crisis," a study warns.

Diseases, Conditions, Syndromes

Ending tuberculosis is a race against time and drug resistance

The tuberculosis (TB) burden in the WHO European Region as a whole is decreasing, and is down 19% overall for 2015-2019, according to the latest WHO/European Center for Disease Prevention and Control (ECDC) report Tuberculosis ...

Diseases, Conditions, Syndromes

S.Africa trial shows promise for drug-resistant TB regimen

Almost all patients who received a new treatment for highly drug-resistant tuberculosis are still clear of the disease two years after a medical trial in South Africa, findings from a long-term study showed Thursday.

page 1 from 16